ArticleRSC advances2024
Accelerated synthesis of 1,8-dioxo-octahydroxanthene and 1,8-dioxo-decahydroacridine derivatives using dendritic mesoporous nanosilica functionalized by hexamethylenetetramine: a novel nanocatalyst.
Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 13 citations in OpenAlex.
- Structural, Morphological, and Textural Characterization of Ni- and Fe-Based KCC-1@C Hybrid Nanocomposites.Nanomaterials (Basel, Switzerland) · 2026Article
- Sequence-Controlled Synthesis of Heteroaryl-Substituted Decahydroacridine-1,8-diones: Comparative Evaluation of Preformed Enaminone and Multicomponent Routes.Molecules (Basel, Switzerland) · 2026Article
- Sustainable catalysis in the synthesis of bis(indolyl)methanes and 1,8-dioxo-octahydroxanthenes using cotton residue-derived sulfonated biochar.RSC advances · 2026Article
- Doughnut-like wrinkled fibrous nano silica architecture as a novel and effective reusable green heterogeneous nanocatalyst for the Hantzsch reaction.Scientific reports · 2025Article
- Accelerated synthesis of 3-dihydroquinazolin-4(1H)-one derivatives using nano-SiOScientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xanthene and acridine derivatives are interesting organic compounds that are used in different research fields like biomedicine and pharmaceutical science. However, applied catalysts for their synthesis have some limitations such as long reaction times, the need for harsh conditions and low yield. So, discovery of novel catalysts for the synthesis of xanthene and acridine derivatives is highly demanded. To overcome the limitation of previous methods on the efficient synthesis of 1,8-dioxo-octahydroxanthene and 1,8-dioxo-decahydroacridine derivatives, a green heterogeneous organic nano-catalyst (Cu@KCC-1-
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.